Diagnostic Histopathology
Volume 14, Issue 2 , Pages 110-115, February 2008

Dysplasia-associated mass or lesion (DALM) and sporadic adenomas in patients with chronic idiopathic inflammatory bowel disease

Simon S Cross MD FRCPath is a Reader in Pathology at Sheffield University, Sheffield, UK

Patricia Vergani MD is a Consultant Histopathologist at Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK

Timothy J Stephenson MD FRCPath is a Consultant Histopathologist at Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK

Mini Varghese FRCPath is a Specialist Registrar in Histopathology at Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK

Reena Sidhu MRCP is a Specialist Registrar in Medicine at Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK

D Paul Hurlstone MD FRCP is a Consultant Gastroenterologist at Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK

published online 27 February 2008.

Abstract 

Dysplasia-associated mass or lesion (DALM) can occur in longstanding idiopathic inflammatory bowel disease, particularly in patients with ulcerative colitis who have had episodes of severe pancolitis over many years. Such patients also develop sporadic adenomas at the same rate as the general population. These cases illustrate features that may be used to distinguish these diseases. In DALM, there is an irregular glandular architecture, positive nuclear p53 staining, negative nuclear beta catenin staining and negative Bcl2 staining. In sporadic adenomas, the glandular architecture is regular, p53 nuclear staining is negative, there is usually strong nuclear staining for beta catenin and positive Bcl2 staining. In the past, a diagnosis of DALM was an indication for panproctocolectomy, but local endoscopic resection and surveillance is sufficient if there is no flat dysplasia in the background colon.

Keywords: Bcl2, beta catenin, colorectal cancer, DALM, p53, sporadic adenoma, ulcerative colitis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1756-2317(07)00131-4

doi:10.1016/j.mpdhp.2007.12.006

Diagnostic Histopathology
Volume 14, Issue 2 , Pages 110-115, February 2008